Haemonetics Corp (NYSE:HAE)

43.96
Delayed Data
As of 2:21pm ET
 -0.32 / -0.72%
Today’s Change
29.86
Today|||52-Week Range
45.43
+17.48%
Year-to-Date
No recent news for Haemonetics Corp.

Today’s Trading

Previous close44.28
Today’s open44.23
Day’s range43.63 - 44.33
Volume110,329
Average volume (3 months)240,019
Market cap$2.3B
Dividend yield--
Data as of 2:21pm ET, 03/03/2015

Growth & Valuation

Earnings growth (last year)-9.46%
Earnings growth (this year)-13.29%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+5.22%
P/E ratio75.8
Price/Sales2.06
Price/Book2.75

Competitors

 Today’s
change
Today’s
% change
GMEDGlobus Medical Inc-0.40-1.64%
HYHHalyard Health Inc-0.22-0.47%
NUVANuVasive Inc-0.60-1.34%
IARTIntegra LifeSciences...-0.43-0.70%
Data as of 2:36pm ET, 03/03/2015

Financials

Next reporting dateApril 27, 2015
EPS forecast (this quarter)$0.52
Annual revenue (last year)$938.5M
Annual profit (last year)$35.1M
Net profit margin3.75%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Brian P. Concannon
Chief Financial Officer &
EVP-Business Development
Christopher J. Lindop
Corporate headquarters
Braintree, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account